Nazzic Keene - Science Applications Sector President of Global Markets and Missions
| SAIC Stock | USD 128.96 0.26 0.20% |
President
Ms. Nazzic S. Keene was appointed as Chief Executive Officer of the company, Effective April 01, 2019. she is no longer as Chief Operating Officer of the Company. Effective April 01, 2019. She served as former Parents Senior Vice President for Corporationrationrate Strategy and Planning from August 2012 to September 2013. Prior to joining us, Ms. Keene was the Senior Vice President and General Manager for U.S. Enterprise Markets at CGI Group, Inc. from 2004. since 2019.
| Age | 63 |
| Tenure | 5 years |
| Address | 12010 Sunset Hills Road, Reston, VA, United States, 20190 |
| Phone | 703 676 4300 |
| Web | https://www.saic.com |
Science Applications Management Efficiency
The company has return on total asset (ROA) of 0.0604 % which means that it generated a profit of $0.0604 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2734 %, meaning that it created $0.2734 on every $100 dollars invested by stockholders. Science Applications' management efficiency ratios could be used to measure how well Science Applications manages its routine affairs as well as how well it operates its assets and liabilities. As of May 2, 2024, Return On Tangible Assets is expected to decline to 0.12. In addition to that, Return On Capital Employed is expected to decline to 0.10. At present, Science Applications' Total Current Assets are projected to decrease significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 155.8 M, whereas Total Assets are forecasted to decline to about 4.7 B.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Denise Williams | Fidelity National Information | 57 | |
| Binod Hampapur | Infosys Ltd ADR | N/A | |
| Gregory Montana | Fidelity National Information | 51 | |
| Sreekanth Arimanithaya | DXC Technology Co | N/A | |
| Boris Shnayder | EPAM Systems | 63 | |
| Ravi S | Infosys Ltd ADR | 48 | |
| Kevin Warren | Conduent | N/A | |
| Vinod Bagal | DXC Technology Co | 58 | |
| Troy Richardson | DXC Technology Co | N/A | |
| Robert Zapfel | Conduent | N/A | |
| Erich Windmuller | DXC Technology Co | N/A | |
| Marc Mayo | Fidelity National Information | 65 | |
| David Nelson | Cognizant Technology Solutions | N/A | |
| Randall King | Conduent | 58 | |
| Jayesh Sanghrajka | Infosys Ltd ADR | 50 | |
| Maruf Majed | DXC Technology Co | N/A | |
| Gary Abrahams | EPAM Systems | 56 | |
| Bruce Lowthers | Fidelity National Information | 55 | |
| David Swift | DXC Technology Co | N/A | |
| James Smith | DXC Technology Co | 51 | |
| Kevin Jones | DXC Technology Co | N/A | |
Management Performance
| Return On Equity | 0.27 | |||
| Return On Asset | 0.0604 |
Science Applications Leadership Team
Elected by the shareholders, the Science Applications' board of directors comprises two types of representatives: Science Applications inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Science. The board's role is to monitor Science Applications' management team and ensure that shareholders' interests are well served. Science Applications' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Science Applications' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edward Sanderson, Independent Chairman of the Board | ||
| Dorothy Helfenstein, Executive Vice President Chief Strategic Growth Officer | ||
| Charles Mathis, CFO, Executive Vice President | ||
| David Kerko, Director | ||
| Yvette Kanouff, Independent Director | ||
| Steven Mahon, Executive Vice President, General Counsel, Secretary | ||
| Donna Morea, Non-Executive Independent Chairman of the Board | ||
| Nathan Rogers, Chief Officer | ||
| Hilary Hageman, General VP | ||
| Douglas Wagoner, Sector President of Services and Solutions | ||
| Joseph DeNardi, Vice Relations | ||
| John Bonsell, Senior Affairs | ||
| Prabu Natarajan, Chief Financial Officer, Executive Vice President | ||
| Garth Graham, Independent Director | ||
| Robert Genter, Executive Vice President and General Manager - Civilian Markets Group | ||
| John Hartley, CFO and Executive VP | ||
| Nazzic Keene, Sector President of Global Markets and Missions | ||
| Mark Escobar, Executive Operations | ||
| Robert Bedingfield, Independent Director | ||
| Steven Shane, Independent Director | ||
| Milford McGuirt, Director | ||
| Paul Levi, Sr. VP, Director of Investor Relations and Corporate Fin. and Treasurer | ||
| Shane Canestra, Director of Investor Relations | ||
| Catherine HernandezBlades, Senior Communications | ||
| Kimberly Admire, Chief HR Officer and Executive VP | ||
| Deborah Dunie, Director | ||
| Michelle OHara, Chief Human Resource Officer, Executive Vice President | ||
| Karen Wheeler, Chief Human Resource Officer | ||
| Paul Greiner, Senior Counsel | ||
| Michael LaRouche, Executive Vice President and General Manager - National Security Group | ||
| Toni TownesWhitley, CEO Director | ||
| Anthony Moraco, CEO, Director, Member of Ethics and Corporate Responsibility Committee and Member of Classified Bus. Oversight Committee | ||
| Maria Bishop, Interim CFO, Interim Principal Accounting Officer and Interim Principal Financial Officer | ||
| Lucy Fitch, Chief VP | ||
| Thomas Frist, Independent Director | ||
| Katharina McFarland, Independent Director | ||
| Carol Goode, Independent Director | ||
| Mark Johnson, Director | ||
| John Hamre, Independent Director | ||
| Timothy Mayopoulos, Independent Director |
Science Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Science Applications a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.27 | |||
| Return On Asset | 0.0604 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 8.84 B | |||
| Shares Outstanding | 51.27 M | |||
| Shares Owned By Insiders | 0.87 % | |||
| Shares Owned By Institutions | 79.27 % | |||
| Number Of Shares Shorted | 515.88 K | |||
| Price To Earning | 30.77 X |
Currently Active Assets on Macroaxis
When determining whether Science Applications offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Science Applications' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Science Applications International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Science Applications International Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Science Applications International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Science Stock analysis
When running Science Applications' price analysis, check to measure Science Applications' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Science Applications is operating at the current time. Most of Science Applications' value examination focuses on studying past and present price action to predict the probability of Science Applications' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Science Applications' price. Additionally, you may evaluate how the addition of Science Applications to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Is Science Applications' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Science Applications. If investors know Science will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Science Applications listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.45) | Dividend Share 1.48 | Earnings Share 8.88 | Revenue Per Share 140.188 | Quarterly Revenue Growth (0.12) |
The market value of Science Applications is measured differently than its book value, which is the value of Science that is recorded on the company's balance sheet. Investors also form their own opinion of Science Applications' value that differs from its market value or its book value, called intrinsic value, which is Science Applications' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Science Applications' market value can be influenced by many factors that don't directly affect Science Applications' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Science Applications' value and its price as these two are different measures arrived at by different means. Investors typically determine if Science Applications is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Science Applications' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.